Refine
Year of publication
Document Type
- Preprint (541)
- Article (318)
- Working Paper (4)
Has Fulltext
- yes (863)
Is part of the Bibliography
- no (863)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron scattering (experiments) (11)
- Hadron-Hadron Scattering (8)
- Heavy-ion collision (5)
- Collective Flow (4)
- Quark-Gluon Plasma (4)
- EEG (3)
- Jets (3)
- Jets and Jet Substructure (3)
- MRI (3)
- Atherosclerosis (2)
- Atmospheric science (2)
- Biomarker (2)
- Bone density (2)
- COVID-19 (2)
- Climate change (2)
- Experimental models of disease (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Heavy Quark Production (2)
- High-throughput screening (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Oncology (2)
- Osteoporosis (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- QCD (2)
- aging (2)
- alpha power (2)
- risk factors (2)
- white matter hyperintensity (2)
- ALICE detector (1)
- Accelerators & Beams (1)
- Accelerators & storage rings (1)
- Aging (1)
- Alpha power (1)
- Alternative splicing (1)
- Anatomic competence (1)
- Anti-nuclei (1)
- Antiviral therapy (1)
- Arthroscopy (1)
- Atmospheric chemistry (1)
- Atomic & molecular beams (1)
- Atomic, Molecular & Optical (1)
- Beam loss (1)
- Bone diseases, Metabolic (1)
- Boosted Jets (1)
- Brain metastasis (1)
- Breast cancer (1)
- CD74 (1)
- CT dual-energy computed tomography (1)
- CVD biomarker (1)
- CXCR4 (1)
- Cancer detection and diagnosis (1)
- Cancer genomics (1)
- Canopy height model (1)
- Cardiovascular diseases (1)
- Charge-transfer collisions (1)
- Chronic hepatitis (1)
- Circular accelerators (1)
- Cirrhosis (1)
- Clinical frailty scale (1)
- Coagulation (1)
- Collective Flow, (1)
- Communicable diseases (1)
- Computational models (1)
- Critical pathway (1)
- Crohn’s disease (1)
- Data sharing (1)
- Diagnostic markers (1)
- Diagnostic techniques and procedures (1)
- Dual-energy computed tomography (1)
- Education (1)
- Electron-pion identification (1)
- Electronic transitions (1)
- Electroweak interaction (1)
- Energy modelling (1)
- European Union (1)
- Fibre/foam sandwich radiator (1)
- Frailty (1)
- Genetic causes of cancer (1)
- Genetic testing (1)
- Germany (1)
- HLA class II (1)
- HLA peptidome (1)
- HNSCC (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hard Scattering (1)
- Head and neck cancer (1)
- Health risk analysis (1)
- Heavy Ion Experiment (1)
- Heavy Ions (1)
- Hepatitis C virus (1)
- Histology (1)
- Human genetics (1)
- Immunology (1)
- Infection control (1)
- Inflammation (1)
- Intensive care outcome (1)
- Ionisation energy loss (1)
- Italy (1)
- Jet Physics (1)
- Jet Substructure (1)
- Knee joint (1)
- LHC (1)
- Loco-regional control (1)
- Low & intermediate-energy accelerators (1)
- Machine learning (1)
- Material budget (1)
- Mechanisms of disease (1)
- Medical (1)
- Medical education (1)
- Mortality (1)
- Multi-Parton Interactions (1)
- Multi-wire proportional drift chamber (1)
- Musculoskeletal ultrasound (1)
- Myocardial infarction (1)
- Myocardial injury (1)
- NOD2 (1)
- Neural network (1)
- Nuclear astrophysics (1)
- Nuclear physics of explosive environments (1)
- Nuclear reactions (1)
- Open data (1)
- Open source (1)
- Osteoporotic fractures (1)
- Ovarian cancer (1)
- Particle and Resonance Production (1)
- Patient isolation (1)
- Pb–Pb collisions (1)
- Phantoms (imaging) (1)
- Photon counting (1)
- Postoperative radiochemotherapy (1)
- Prognostic (1)
- Properties of Hadrons (1)
- Protease inhibitor therapy (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- RNA (1)
- RNA-binding proteins (1)
- Radiative capture (1)
- Radiomics (1)
- Randomized controlled trial (1)
- Relativistic heavy-ion collisions (1)
- Respiratory signs and symptoms (1)
- Resting-state (1)
- Reverse transcription polymerase chain reaction (1)
- SARS-CoV-2 (1)
- SDF-1 (1)
- Shoulder joint (1)
- Specimen preparation and treatment (1)
- Stroke (1)
- Students (1)
- Sweden (1)
- TR (1)
- Tomography (x-ray computed) (1)
- Tracking (1)
- Transition radiation detector (1)
- Translational research (1)
- Trauma (1)
- Trichuris suis ova (1)
- Trigger (1)
- Tumor infiltrating lymphocytes (1)
- UAV (1)
- VIP1 (1)
- Validation (1)
- Vector Boson Production (1)
- Viral load (1)
- White matter hyperintensity (1)
- X-ray crystallography (1)
- Xenon-based gas mixture (1)
- amino acids (1)
- aortic stenosis (1)
- cardiac remodeling (1)
- clinical immunology (1)
- dE/dx (1)
- detector (1)
- drone (1)
- experimental results (1)
- fine spatial resolution remote sensing (1)
- global change (1)
- habitat destruction (1)
- heart failure (1)
- heavy ion experiments (1)
- helminths (1)
- image-based risk modelling (1)
- immunosuppression (1)
- infection (1)
- innate immunity (1)
- land use (1)
- lymphocytes (1)
- machine learning (1)
- mortality risk (1)
- neutralizing antibodies (1)
- personalised therapy (1)
- plant height (1)
- pneumocystis (1)
- quark gluon plasma (1)
- radiation oncology (1)
- radiomic (1)
- rats (1)
- renal transplantation (1)
- resting-state (1)
- risk factor progression (1)
- spike protein (1)
- structure-from-motion photogrammetry (1)
- survival (1)
- transplantation (1)
- variants of concern (1)
- x-ray techniques (1)
Institute
- Physik (810)
- Frankfurt Institute for Advanced Studies (FIAS) (750)
- Informatik (715)
- Medizin (28)
- Geowissenschaften (7)
- ELEMENTS (6)
- Geowissenschaften / Geographie (5)
- Biodiversität und Klima Forschungszentrum (BiK-F) (4)
- Informatik und Mathematik (3)
- Senckenbergische Naturforschende Gesellschaft (3)
TRIANNI mice carry an entire set of human immunoglobulin V region gene segments and are a powerful tool to rapidly isolate human monoclonal antibodies. After immunizing these mice with DNA encoding the spike protein of SARS-CoV-2 and boosting with spike protein, we identified 29 hybridoma antibodies that reacted with the SARS-CoV-2 spike protein. Nine antibodies neutralize SARS-CoV-2 infection at IC50 values in the subnanomolar range. ELISA-binding studies and DNA sequence analyses revealed one cluster of three clonally related neutralizing antibodies that target the receptor-binding domain and compete with the cellular receptor hACE2. A second cluster of six clonally related neutralizing antibodies bind to the N-terminal domain of the spike protein without competing with the binding of hACE2 or cluster 1 antibodies. SARS-CoV-2 mutants selected for resistance to an antibody from one cluster are still neutralized by an antibody from the other cluster. Antibodies from both clusters markedly reduced viral spread in mice transgenic for human ACE2 and protected the animals from SARS-CoV-2-induced weight loss. The two clusters of potent noncompeting SARS-CoV-2 neutralizing antibodies provide potential candidates for therapy and prophylaxis of COVID-19. The study further supports transgenic animals with a human immunoglobulin gene repertoire as a powerful platform in pandemic preparedness initiatives.
New experimental data for dissociation of relativistic 17Ne projectiles incident on targets of lead, carbon, and polyethylene targets at GSI are presented. Special attention is paid to the excitation and decay of narrow resonant states in 17Ne. Distributions of internal energy in the three-body system have been determined together with angular and partial-energy correlations between the decay products in different energy regions. The analysis was done using existing experimental data on 17Ne and its mirror nucleus 17N. The isobaric multiplet mass equation is used for assignment of observed resonances and their spins and parities. A combination of data from the heavy and light targets yielded cross sections and transition probabilities for the Coulomb excitations of the narrow resonant states. The resulting transition probabilities provide information relevant for a better understanding of the 17Ne structure.
Relationship between regional white matter hyperintensities and alpha oscillations in older adults
(2021)
Aging is associated with increased white matter hyperintensities (WMHs) and with the alterations of alpha oscillations (7–13 Hz). However, a crucial question remains, whether changes in alpha oscillations relate to aging per se or whether this relationship is mediated by age-related neuropathology like WMHs. Using a large cohort of cognitively healthy older adults (N=907, 60-80 years), we assessed relative alpha power, alpha peak frequency, and long-range temporal correlations (LRTC) from resting-state EEG. We further associated these parameters with voxel-wise WMHs from 3T MRI. We found that a higher prevalence of WMHs in the superior and posterior corona radiata as well as in the thalamic radiation was related to elevated alpha power, with the strongest association in the bilateral occipital cortex. In contrast, we observed no significant relation of the WMHs probability with alpha peak frequency and LRTC. Finally, higher age was associated with elevated alpha power via total WMH volume. Although an increase in alpha oscillations due to WMH can have a compensatory nature, we rather suggest that an elevated alpha power is a consequence of WMH affecting a spatial organization of alpha sources.
Das 2. UmwG-ÄndG bringt hinsichtlich der grenzüberschreitenden Verschmelzung einen erheblichen Gewinn an Rechtssicherheit. Weil die §§ 122a ff. UmwG-E weitgehend eine getreue Umsetzung der IntVRiL darstellen, werden künftige transnationale Verschmelzungen erleichtert; dies jedenfalls dann, wenn auch die anderen EU-Mitgliedstaaten die Richtlinie alsbald umsetzen. Anders als bei innerstaatlichen Verschmelzungen sind die für die Arbeitnehmer wesentlichen Informationen nicht im Verschmelzungsvertrag bzw. -plan, sondern im Verschmelzungsbericht enthalten. Dementsprechend ist dieser nicht verzichtbar. Sofern ein Verhandlungsverfahren über die künftige Mitbestimmung nach MgVG stattfindet, können sich die Anteilseigner die Bestätigung der dort erzielten Ergebnisse vorbehalten (§ 122g Abs. 1 UmwG-E), wenn die Verhandlungen im Zeitpunkt der Zustimmung zur Verschmelzung noch nicht beendet sind. Für die Bestätigung können andere Beschlussmodalitäten vorgesehen werden als für den Verschmelzungsbeschluss selbst. § 122c Abs. 2 Nr. 11, 12 UmwG-E ist dahingehend teleologisch zu reduzieren, dass die dort geforderten Angaben entfallen können, wenn sie für die Umsetzung und bilanzielle Abbildung der Verschmelzung nach den beteiligten Rechtsordnungen nicht erforderlich sind. Eine Zustimmung der Anteilseigner ausländischer Rechtsträger zur Durchführung eines Spruchverfahrens wird regelmäßig nicht zu erlangen sein. In diesem Fall sind die Gesellschafter des deutschen übertragenden Rechtsträgers – abweichend von § 14 Abs. 2 UmwG – auf die Anfechtungsklage verwiesen. Findet demgegenüber ein Spruchverfahren statt, insbesondere weil alle beteiligten Rechtsordnungen ein solches vorsehen, wird die vom Gesetzgeber gewünschte Zuständigkeitskonzentration kaum je zu erreichen sein. Regelmäßig werden nämlich die Gerichte in den Sitzstaaten sowohl des übertragenden als auch des übernehmenden Rechtsträgers international zuständig sein. Die Vorschrift des § 6c SpruchG-E ist dahingehend teleologisch zu reduzieren, dass ein gemeinsamer Vertreter nur für solche Anteilseigner zu bestellen ist, deren Zustimmung nach § 122h Abs. 1 UmwG-E zur Durchführung des Spruchverfahrens erforderlich ist. Auch in den vom 2. UmwG-ÄndG nicht geregelten Fälle internationaler Umwandlungen (insbesondere Verschmelzung unter Beteiligung von Personengesellschaften und Spaltung) kann weitgehend auf die in §§ 122a ff. UmwG-E enthaltenen Rechtsgedanken zurückgegriffen werden.
Background: Highly infectious diseases (HIDs) are defined as being transmissible from person to person, causing life-threatening illnesses and presenting a serious public health hazard. The sampling, handling and transport of specimens from patients with HIDs present specific bio-safety concerns. Findings The European Network for HID project aimed to record, in a cross-sectional study, the infection control capabilities of referral centers for HIDs across Europe and assesses the level of achievement to previously published guidelines. In this paper, we report the current diagnostic capabilities and bio-safety measures applied to diagnostic procedures in these referral centers. Overall, 48 isolation facilities in 16 European countries were evaluated. Although 81% of these referral centers are located near a biosafety level 3 laboratory, 11% and 31% of them still performed their microbiological and routine diagnostic analyses, respectively, without bio-safety measures.
Conclusions: The discrepancies among the referral centers surveyed between the level of practices and the European Network of Infectious Diseases (EUNID) recommendations have multiple reasons of which the interest of the individuals in charge and the investment they put in preparedness to emerging outbreaks. Despite the fact that the less prepared centers can improve by just updating their practice and policies any support to help them to achieve an acceptable level of biosecurity is welcome.
We report the first measurement of low-energy proton-capture cross sections of 124Xe in a heavy-ion storage ring. 124Xe54+ ions of five different beam energies between 5.5 and 8 AMeV were stored to collide with a windowless hydrogen target. The 125Cs reaction products were directly detected. The interaction energies are located on the high energy tail of the Gamow window for hot, explosive scenarios such as supernovae and x-ray binaries. The results serve as an important test of predicted astrophysical reaction rates in this mass range. Good agreement in the prediction of the astrophysically important proton width at low energy is found, with only a 30% difference between measurement and theory. Larger deviations are found above the neutron emission threshold, where also neutron and γ widths significantly impact the cross sections. The newly established experimental method is a very powerful tool to investigate nuclear reactions on rare ion beams at low center-of-mass energies.
Low serum concentrations of the amino acid homoarginine (HA) are associated with increased cardiovascular mortality by incompletely understood mechanisms. This study sought to assess the influence of HA on cardiac remodeling in rats undergoing either transaortic banding or inhibition of nitric oxide synthesis by Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME). Male Wistar rats (n = 136) underwent sham operation (SH) or aortic banding (AB). Both groups were equally divided into 14 subgroups, receiving different doses of HA alone or in combination with lisinopril, spironolactone, or L-NAME for 4 weeks. HA treatment in AB animals resulted in a dose-dependent improvement of cardiac function up to a concentration of 800 mg·kg−1·day−1. Combining 800 mg·kg−1·day−1 HA with spironolactone or lisinopril yielded additional effects, showing a positive correlation with LV ejection fraction (+33%, p = 0.0002) and fractional shortening (+41%, p = 0.0014). An inverse association was observed with collagen area fraction (−41%, p < 0.0001), myocyte cross-sectional area (−22%, p < 0.0001) and the molecular markers atrial natriuretic factor (−74%, p = 0.0091), brain natriuretic peptide (−42%, p = 0.0298), beta-myosin heavy chain (−46%, p = 0.0411), and collagen type V alpha 1 chain (−73%, p = 0.0257) compared to placebo-treated AB animals. Co-administration of HA and L-NAME was found to attenuate cardiac remodeling and prevent NO-deficient hypertension following AB. HA treatment has led to a dose-dependent improvement of myocardial function and marked histological and molecular changes in cardiac remodeling following AB. Combining HA with standard heart failure medication resulted in additional beneficial effects boosting its direct impact on heart failure pathophysiology.
The 124Xe(p,γ) reaction has been measured for the first time at energies around the Gamow window by using stored ions at the ESR facility. The desired beam energies below 10 MeV/u introduce new experimental challenges like windowless ions detection under UHV conditions, extremely short beam lifetimes and efficient beam deceleration and cooling, all of which have been successfully met.
Comprehensive analysis of tumour sub-volumes for radiomic risk modelling in locally advanced HNSCC
(2020)
Simple Summary: Radiomic risk models are usually based on imaging features, which are extracted from the entire gross tumour volume (GTV entire ). This approach does not explicitly consider the complex biological structure of the tumours. Therefore, in this retrospective study, we investigated the prognostic value of radiomic analyses based on different tumour sub-volumes using computed tomography imaging of patients with locally advanced head and neck squamous cell carcinoma who were treated with primary radio-chemotherapy. The GTV entire was cropped by different margins to define the rim and corresponding core sub-volumes of the tumour. Furthermore, the best performing tumour rim sub-volume was extended into surrounding tissue with different margins. As a result, the models based on the 5 mm tumour rim and on the 3 mm extended rim sub-volume showed an improved performance compared to models based on the corresponding tumour core. This indicates that the consideration of tumour sub-volumes may help to improve radiomic risk models.
Abstract: Imaging features for radiomic analyses are commonly calculated from the entire gross tumour volume (GTVentire). However, tumours are biologically complex and the consideration of different tumour regions in radiomic models may lead to an improved outcome prediction. Therefore, we investigated the prognostic value of radiomic analyses based on different tumour sub-volumes using computed tomography imaging of patients with locally advanced head and neck squamous cell carcinoma. The GTVentire was cropped by different margins to define the rim and the corresponding core sub-volumes of the tumour. Subsequently, the best performing tumour rim sub-volume was extended into surrounding tissue with different margins. Radiomic risk models were developed and validated using a retrospective cohort consisting of 291 patients in one of the six Partner Sites of the German Cancer Consortium Radiation Oncology Group treated between 2005 and 2013. The validation concordance index (C-index) averaged over all applied learning algorithms and feature selection methods using the GTVentire achieved a moderate prognostic performance for loco-regional tumour control (C-index: 0.61 ± 0.04 (mean ± std)). The models based on the 5 mm tumour rim and on the 3 mm extended rim sub-volume showed higher median performances (C-index: 0.65 ± 0.02 and 0.64 ± 0.05, respectively), while models based on the corresponding tumour core volumes performed less (C-index: 0.59 ± 0.01). The difference in C-index between the 5 mm tumour rim and the corresponding core volume showed a statistical trend (p = 0.10). After additional prospective validation, the consideration of tumour sub-volumes may be a promising way to improve prognostic radiomic risk models.
Purpose: To develop and validate a CT-based radiomics signature for the prognosis of loco-regional tumour control (LRC) in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated by primary radiochemotherapy (RCTx) based on retrospective data from 6 partner sites of the German Cancer Consortium - Radiation Oncology Group (DKTK-ROG).
Material and methods: Pre-treatment CT images of 318 patients with locally advanced HNSCC were collected. Four-hundred forty-six features were extracted from each primary tumour volume and then filtered through stability analysis and clustering. First, a baseline signature was developed from demographic and tumour-associated clinical parameters. This signature was then supplemented by CT imaging features. A final signature was derived using repeated 3-fold cross-validation on the discovery cohort. Performance in external validation was assessed by the concordance index (C-Index). Furthermore, calibration and patient stratification in groups with low and high risk for loco-regional recurrence were analysed.
Results: For the clinical baseline signature, only the primary tumour volume was selected. The final signature combined the tumour volume with two independent radiomics features. It achieved moderately good discriminatory performance (C-Index [95% confidence interval]: 0.66 [0.55–0.75]) on the validation cohort along with significant patient stratification (p = 0.005) and good calibration.
Conclusion: We identified and validated a clinical-radiomics signature for LRC of locally advanced HNSCC using a multi-centric retrospective dataset. Prospective validation will be performed on the primary cohort of the HNprädBio trial of the DKTK-ROG once follow-up is completed.